Selected Publications:

Cord Blood Project

  1. Ellis AK, Crawford L, Denburg JA. Cord blood CD34+ hemopoietic progenitor eosinophilic lineage commitment assessed by Q-PCR. JACI 2009; [Abs] in press.
  2. Denburg JA, Fernandes R, Ellis AK, Cyr M, Crawford L, Kusel M, Holt K, Holt B, Kebadze T, Johnston SL, Sly P, Prescott S, Holt PG. Eosinophil progenitors at birth: intimations of future atopy and inflammation. Allergy Clin Immunol Int: J World Allergy Org, Supplement 2 (2007), pp 29-31.
  3. Ellis AK, Crawford L, Denburg JA. Molecular Markers of Eosinophilopoiesis: Multiplex Q-PCR Analysis of GATA-1, MBP and IL-5 Receptor mRNA Expression in Peripheral Blood. J Allergy Clin Immunol 2007
  4. Crawford L, Ellis AK, Denburg JA. Kinetics of Cord Blood Eosinophil Lineage Biomarker mRNA: Co-expression of CysLTR1 with GATA-1. J Allergy Clin Immunol 2007
  5. Ellis AK, Crawford L, Denburg JA. Molecular Markers of Eosinophilopoiesis: Multiplex Q-PCR Analysis of GATA-1, MBP and IL-5 Receptor mRNA Expression in Peripheral Blood. Allergy, Asthma and Clinical Immunology 2006; 2(4): 140.
  6. Ellis AK, Crawford L, Denburg JA. Molecular Mechanisms of Eosinophilopoesis at Birth: Kinetics of Cord Blood GATA-1, MBP and IL-5 Receptor Expression. J Allergy Clin Immunol 2006; 117(2): S60.

Allergic Rhinitis Projects 

  1. Day JH, Ellis AK, Rafeiro E, Ratz JD, Briscoe MP. Experimental Models for the Evaluation of Treatment of Allergic Rhinitis. Annals of Allergy, Asthma and Immunology 2006; 96(2): 263-278.
  2. Day JH, Briscoe MP, Rafeiro E, Ratz JD, Ellis AK, Frankish CW, Chapman D, deGuia EC, Kramer B, Warner C. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours post-dose, in the Environmental Exposure Unit. Allergy Asthma Proc 2005; 26(4): 275-82.
  3. Ellis AK, Ratz JD, Day A, Rafeiro E, Day JH. Factors affecting the allergic rhinitis response to ragweed allergen. Allergy, Asthma and Clinical Immunology 2005; 1(3): 104-5.
  4. Ellis AK, Ratz JD, Heffer MJ, Day JH. The allergic rhinitis experience: A self-reported patient evaluation of symptomatology and medication use during ragweed season. Allergy, Asthma and Clinical Immunology 2005; 1(3): 105
  5. Ellis AK, Rafeiro E, Ratz JD, Day JH. The Controlled Allergen Challenge Experience: Comparison of Allergic Upper Respiratory Symptoms in the Environmental Exposure Unit (EEU) and During Seasonal Exposure. Annals of Allergy, Asthma and Immunology 2005; 94(1): Abs 244.
  6. Ellis AK, Rafeiro E, Day JH. Quality of life indices may be predictive of placebo and medication response to treatment for allergic rhinitis. Ann Asthma Allergy Immunol 2001; 86(4): 393-6.
  7. Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol 2003; 91(4): 375-85.
  8. Day JH, Briscoe MP, Rafeiro E, Ellis AK, Petterson E, Akerlund A. Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol 2000 105(3): 489-94.
  9. Ellis AK, Day JH, Lundie MJ. Impact on Quality of Life in an Allergen Challenge Research Trial. Ann Allergy Asthma Immunol 1999; 83: 33-39.
  10. Day JH, Briscoe MP, Welsh A, Smith JN, Clark AJ, Ellis AK, and Mason J. Onset of action, efficacy, and safety of a single dose of fexofenadine HCl for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 1997; 79(6): 533-40.
  11. Day JH, Briscoe MP, Clark RH, Ellis AK, and Gervais P. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79(2): 163-72.

Anaphylaxis

  1. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol. 2007; 98: 64-9.
  2. Ellis AK, Day JH. Management of anaphylaxis in a tertiary care emergency department. Allergy, Asthma and Clinical Immunology 2006; 2(4): 138.
  3. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. Can Med Assoc J 2003; 169(4): 307-12.
  4. Ellis AK, Day JH. Anaphylaxis treatment: the details. Can Med Assoc J 2003; 169: 1148-9.
  5. Ellis AK, Day, JH. Questions and answers about anaphylaxis. An information sheet for patients. Can Med Assoc J 2003; 169(4): 312.
  6. Ellis AK, Day JH. The role of epinephrine in the treatment of anaphylaxis. Curr Allergy Asthma Rep 2003; 3(1): 11-4.
  7. Ellis AK, Day JH. Anaphylaxis: Diagnosis and Treatment. Allergy & Asthma 2000; 13(3): 22-35.
  8. Ellis AK, Day JH. Biphasic Anaphylaxis with Unusually Late Onset Second Phase: A Case Report. Can J Allergy Clin Immunol 1997; 2(3): 106-9.

Other Publications of Interest:

  1. Ellis AK, Keith PK. Non-allergic rhinitis with eosinophilia syndrome. Current Allergy and Asthma Reports. 2006 May; 6(3): 215-20.
  2. Ellis AK, Day JH. Clinical reactivity to insect stings. Curr Opin Allergy Clin Immunol 2005; 5: 349-54.
  3. Day JH, Ellis AK, Rafeiro E. Levocetirizine: A new selective H1 receptor antagonist for use in allergic disorders. Drugs of Today 2004; 40(5): 415-21.
  4. Ellis AK, Day JH. Second and third generation antihistamines in the treatment of urticaria. Dermatologic Therapy 2000; 13(4): 327-36.
  5. Ellis AK, Day JH. Allergy to Insect Bites and Stings. Allergy 1996; 9(3): 18-22.

Textbook Chapter:

  1. Ellis AK, Day JH. Allergenic Microorganisms and Hypersensitivity. In: Flannigan BF and Miler JD, eds. Microorganism in Home and Indoor Work Environments, 2nd edition. Taylor and Francis, 2009, New York, in press.
  2. Ellis AK, Day JH. Insect Sting Allergy in Adults. In: Pawankar R, Holgate S, and Rosenwasser LJ, eds. Allergy Frontiers. From Epigenetics to Future Perspectives. Springer Japan KK, Tokyo, Japan 2009; in press.
  3. Ellis AK, Keith PK. Nonallergic Rhinitis with Eosinophilia Syndrome. In: Baraniuk J, Shusterman D. Nonallergic Rhinitis, Marcel Dekker Clinical Allergy and Immunology Series. Michael A. Kaliner, MD, Editor in Chief. Informa Healthcare USA, Inc 2007, New York: 87-100.
  4. Day JH, Ellis AK. Allergenic Microorganisms and Hypersensitivity. In: Flannigan BF, Sampson RA and Miller JD, eds. Microorganisms in Home and Indoor Work Environments. Taylor and Francis 2001, New York. 103